“Pharma bro” Martin Shkreli is still ruffling feathers days after being transferred to his new crib at a Pennsylvania facility.
On Friday, a lawsuit filed in a federal court in Manhattan revealed that the notorious 36-year-old former hedge fund manager is seeking more than $30 million in damages against his three former colleagues at Retrophin, alleging they “illegally” ousted him as the drug developer’s chief in 2014.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,